Dr. Jimmy J Zuniga is a Pleasanton, Texas based male chiropractor who is specialized as General Chiropractor. Active license number of Dr. Jimmy J Zuniga as General Chiropractor is 6805 in Texas. Dr. Jimmy J Zuniga is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Jimmy J Zuniga speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
D.C.
Gender:
Male
Practice Address:
220 W Goodwin St Ste C, Pleasanton, Texas, 78064-4119
Phone:
830-569-2167
Fax:
830-569-5958
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1295728384
NPI Enumeration Date:
24 Aug, 2005
NPI Last Update On:
10 Dec, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jimmy J Zuniga are as mentioned below.
License Number
Specialization
State
Status
6805
Chiropractor
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
220 W Goodwin St Ste C, Pleasanton, Texas
Zip:
78064-4119
Phone Number:
830-569-2167
Fax Number:
830-569-5958
Patients can reach Dr. Jimmy J Zuniga at 220 W Goodwin St Ste C, Pleasanton, Texas or can call to book an appointment on 830-569-2167. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.